Gilead to Buy Maker of Cancer Treatments for $11.9 Billion

By MICHAEL J. de la MERCED from NYT Business Day http://ift.tt/2iDFsAb
via IFTTTThe deal to acquire Kite, whose drugs use the body’s immune system as a weapon, is Gilead’s biggest effort to date to find a new blockbuster product. August 28, 2017 at 01:00AM